No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Approval Alert: Celltrion’s Aflibercept Biosimilar Approved in Korea
On 30 May 2024, the Korea IT Times reported that Celltrion announced it received domestic approval from South Korea's Ministry of Food and Drug Safety for EydenzeltTM (CT-P42), biosimilar to Regeneron's Eylea® (aflibercept). Eydenzelt was approved for the same...